Cargando…
Selecting the Target Population for Screening of Hepatic Fibrosis in Primary Care Centers in Korea
Screening strategies for hepatic fibrosis are heavily focused on patients with fatty liver on sonography in primary care centers. This study aimed to investigate the target population for screening significant hepatic fibrosis in primary care centers. This retrospective cross-sectional cohort study...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953170/ https://www.ncbi.nlm.nih.gov/pubmed/35329799 http://dx.doi.org/10.3390/jcm11061474 |
_version_ | 1784675783573241856 |
---|---|
author | Park, Huiyul Yoon, Eileen L. Kim, Mimi Cho, Seon Kim, Jung-Hwan Jun, Dae Won Nah, Eun-Hee |
author_facet | Park, Huiyul Yoon, Eileen L. Kim, Mimi Cho, Seon Kim, Jung-Hwan Jun, Dae Won Nah, Eun-Hee |
author_sort | Park, Huiyul |
collection | PubMed |
description | Screening strategies for hepatic fibrosis are heavily focused on patients with fatty liver on sonography in primary care centers. This study aimed to investigate the target population for screening significant hepatic fibrosis in primary care centers. This retrospective cross-sectional cohort study used data from 13 nationwide centers. A total of 5111 subjects who underwent both abdominal sonography and magnetic resonance elastography as part of their health check-up were included. Subjects with viral hepatitis and/or a history of significant alcohol consumption were excluded. Significant and advanced hepatic fibrosis was defined as ≥3.0 kPa and ≥3.6 kPa in the MRE test, respectively. The prevalence of significant and advanced hepatic fibrosis was 7.3% and 1.9%, respectively. Among the subjects with significant hepatic fibrosis, 41.3% did not have fatty liver. Hepatic fibrosis burden increased according to the number of metabolic risk abnormalities. Nearly 70% of subjects with significant hepatic fibrosis also had two or more metabolic risk abnormalities and/or diabetes. However, the prevalence of fibrosis did not differ between the groups with and without fatty liver. The presence of two or more metabolic risk abnormalities was an independent risk factor for significant hepatic fibrosis regardless of the fatty liver. Therefore, in the setting of primary care centers, screening for hepatic fibrosis would better be extended to subjects with metabolically unhealthy status beyond those with fatty liver. |
format | Online Article Text |
id | pubmed-8953170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89531702022-03-26 Selecting the Target Population for Screening of Hepatic Fibrosis in Primary Care Centers in Korea Park, Huiyul Yoon, Eileen L. Kim, Mimi Cho, Seon Kim, Jung-Hwan Jun, Dae Won Nah, Eun-Hee J Clin Med Article Screening strategies for hepatic fibrosis are heavily focused on patients with fatty liver on sonography in primary care centers. This study aimed to investigate the target population for screening significant hepatic fibrosis in primary care centers. This retrospective cross-sectional cohort study used data from 13 nationwide centers. A total of 5111 subjects who underwent both abdominal sonography and magnetic resonance elastography as part of their health check-up were included. Subjects with viral hepatitis and/or a history of significant alcohol consumption were excluded. Significant and advanced hepatic fibrosis was defined as ≥3.0 kPa and ≥3.6 kPa in the MRE test, respectively. The prevalence of significant and advanced hepatic fibrosis was 7.3% and 1.9%, respectively. Among the subjects with significant hepatic fibrosis, 41.3% did not have fatty liver. Hepatic fibrosis burden increased according to the number of metabolic risk abnormalities. Nearly 70% of subjects with significant hepatic fibrosis also had two or more metabolic risk abnormalities and/or diabetes. However, the prevalence of fibrosis did not differ between the groups with and without fatty liver. The presence of two or more metabolic risk abnormalities was an independent risk factor for significant hepatic fibrosis regardless of the fatty liver. Therefore, in the setting of primary care centers, screening for hepatic fibrosis would better be extended to subjects with metabolically unhealthy status beyond those with fatty liver. MDPI 2022-03-08 /pmc/articles/PMC8953170/ /pubmed/35329799 http://dx.doi.org/10.3390/jcm11061474 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Park, Huiyul Yoon, Eileen L. Kim, Mimi Cho, Seon Kim, Jung-Hwan Jun, Dae Won Nah, Eun-Hee Selecting the Target Population for Screening of Hepatic Fibrosis in Primary Care Centers in Korea |
title | Selecting the Target Population for Screening of Hepatic Fibrosis in Primary Care Centers in Korea |
title_full | Selecting the Target Population for Screening of Hepatic Fibrosis in Primary Care Centers in Korea |
title_fullStr | Selecting the Target Population for Screening of Hepatic Fibrosis in Primary Care Centers in Korea |
title_full_unstemmed | Selecting the Target Population for Screening of Hepatic Fibrosis in Primary Care Centers in Korea |
title_short | Selecting the Target Population for Screening of Hepatic Fibrosis in Primary Care Centers in Korea |
title_sort | selecting the target population for screening of hepatic fibrosis in primary care centers in korea |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953170/ https://www.ncbi.nlm.nih.gov/pubmed/35329799 http://dx.doi.org/10.3390/jcm11061474 |
work_keys_str_mv | AT parkhuiyul selectingthetargetpopulationforscreeningofhepaticfibrosisinprimarycarecentersinkorea AT yooneileenl selectingthetargetpopulationforscreeningofhepaticfibrosisinprimarycarecentersinkorea AT kimmimi selectingthetargetpopulationforscreeningofhepaticfibrosisinprimarycarecentersinkorea AT choseon selectingthetargetpopulationforscreeningofhepaticfibrosisinprimarycarecentersinkorea AT kimjunghwan selectingthetargetpopulationforscreeningofhepaticfibrosisinprimarycarecentersinkorea AT jundaewon selectingthetargetpopulationforscreeningofhepaticfibrosisinprimarycarecentersinkorea AT naheunhee selectingthetargetpopulationforscreeningofhepaticfibrosisinprimarycarecentersinkorea |